Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-16-013054
Filing Date
2016-02-10
Accepted
2016-02-10 19:57:14
Documents
2
Period of Report
2016-02-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1588
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4495
  Complete submission text file 0000899243-16-013054.txt   7336
Mailing Address
Business Address
PIERCE GLENN (Reporting) CIK: 0001256964 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37539 | Film No.: 161407541

Mailing Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Issuer) CIK: 0001629137 (see all company filings)

EIN.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations